These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25404096)

  • 21. Familial hypercholesterolaemia: optimum treatment strategies.
    Ballantyne CM
    Int J Clin Pract Suppl; 2002 Jul; (130):22-6. PubMed ID: 12296605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effects of LDL apheresis in patients with severe hypercholesterolemia.
    Sachais BS; Katz J; Ross J; Rader DJ
    J Clin Apher; 2005 Dec; 20(4):252-5. PubMed ID: 15880364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expert consensus on the detection and clinical management of familial hypercholesterolemia].
    Masana L; Civeira F; Pedro-Botet J; de Castro I; Pocoví M; Plana N; Mateo-Gallego R; Jarauta E; Pedragosa À
    Clin Investig Arterioscler; 2013; 25(4):182-93. PubMed ID: 24041477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S1-8. PubMed ID: 21600525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Halvorsen B; Ose L; Aukrust P; Holven KB
    Cytokine; 2013 Jan; 61(1):194-8. PubMed ID: 23131422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.
    Ten Kate GR; Bos S; Dedic A; Neefjes LA; Kurata A; Langendonk JG; Liem A; Moelker A; Krestin GP; de Feyter PJ; Roeters van Lennep JE; Nieman K; Sijbrands EJ
    J Am Coll Cardiol; 2015 Dec; 66(24):2687-2695. PubMed ID: 26700830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
    Page MM; Stefanutti C; Sniderman A; Watts GF
    Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical applications of long-term LDL-apheresis on and beyond refractory hypercholesterolemia.
    Mabuchi H; Higashikata T; Kawashiri MA
    Transfus Apher Sci; 2004 Jun; 30(3):233-43. PubMed ID: 15172629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
    Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life.
    Nagasaka H; Miida T; Hirano K; Ota A; Yorifuji T; Takatani T; Tsukahara H; Takayanagi M; Hui SP; Kobayashi K; Chiba H
    J Clin Endocrinol Metab; 2008 Mar; 93(3):779-83. PubMed ID: 18182454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advances in diagnosis and treatment of familial hypercholesterolemia].
    Zheng H; Jiang S; Lin L
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):153-156. PubMed ID: 36856225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowns and unknowns in the care of pediatric familial hypercholesterolemia.
    Martin AC; Gidding SS; Wiegman A; Watts GF
    J Lipid Res; 2017 Sep; 58(9):1765-1776. PubMed ID: 28701353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia.
    Nenseter MS; Lindvig HW; Ueland T; Langslet G; Ose L; Holven KB; Retterstøl K
    Atherosclerosis; 2011 Jun; 216(2):426-32. PubMed ID: 21376325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Developments in the Care of Familial Hypercholesterolemia: Where Now and Where to Next?
    Pang J; Lansberg PJ; Watts GF
    J Atheroscler Thromb; 2016 May; 23(5):505-19. PubMed ID: 26903443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17).
    Miller PE; Martin SS; Toth PP; Santos RD; Blaha MJ; Nasir K; Virani SS; Post WS; Blumenthal RS; Jones SR
    J Clin Lipidol; 2015; 9(5):676-83. PubMed ID: 26350814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.